Avadel Pharma Earnings miss, Revenue Inline In Q1

Investing.com - Avadel Pharma reported first quarter earnings that missed analysts' expectations on Monday and revenue that was inline with forecasts.
The firm reported earnings per share of $-0.45 on revenue of $0.00. Analysts polled by Investing.com expected EPS of $-0.4329 on revenue of $0.00. .
Avadel Pharma shares gained 0.48% to trade at $4.200 in intra-day trade following the report.
For the year, Avadel Pharma shares are down 48.02%, under-performing the Nasdaq which is down 24.07% year to date.
Avadel Pharma follows other major Healthcare sector earnings this month
On Thursday, April 14, 2022, UnitedHealth reported first quarter EPS of $5.49 on revenue of $80.15B, compared to forecasts of EPS of $5.36 on revenue of $78.73B.
J&J earnings beat analyst's expectations on Tuesday, April 19, 2022, with first quarter EPS of $2.67 on revenue of $23.43B. Investing.com analysts expected EPS of $2.59 on revenue of $23.62B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb
Drop an image here or